IC’s proprietary process generates a more personalized asset allocation for consumers by incorporating non-traditional factors like human capital & real estate.
Advancing Imaging Biomarkers as Phenotypic Endpoints for Body Analytics, in order to replace invasive diagnostic procedures. Virtual Liver Biopsy by LiverMap.